Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Vor Biopharma Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 71 | 59 | −12 |
| Shares | 60.8M | 60.2M | −561.1K (−0.9%) |
| Value | $187.8M | $127.7M | −$60.1M (−32.0%) |
New holders (2)
Institutions that held Vor Biopharma Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SG Americas Securities, LLC | 17,258 | $37.0K | 0.00% |
| Gladius Capital Management LP | 10,009 | $21.2K | 0.01% |
Sold out (14)
Institutions that held Vor Biopharma Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jane Street Group, LLC | 92,462 | $285.7K |
| Parkwood LLC | 73,930 | $228.0K |
| Millennium Management LLC | 62,690 | $193.7K |
| Two Sigma Investments, LP | 28,090 | $86.8K |
| Mirae Asset Global Investments Co., Ltd. | 21,509 | $66.5K |
| MetLife Investment Management | 21,190 | $65.5K |
| Tucker Asset Management LLC | 19,453 | $60.1K |
| Jump Financial, LLC | 18,600 | $57.5K |
| Virtu Financial LLC | 11,765 | $36.0K |
| State Board of Administration of Florida Retirement System | 10,700 | $33.1K |
| Denali Advisors LLC | 6,500 | $20.1K |
| Metropolitan Life Insurance Co | 2,196 | $6.79K |
| Northwestern Mutual Wealth Management Co | 250 | $773 |
| Simplex Trading, LLC | 293 | $0 |